← Leaderboards
Raghavan Murugan
University Of Pittsburgh At Pittsburgh
$2,408,521
Attributed
$4,536,610
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $968.4K · FY2016–24$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,536,610 · 3
By mechanism
R01$4,536,610 · 3
Top collaborators
- Kianoush B Kashani7 shared
- Gilles Clermont4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Bill J Yates$10,406,888
- Teresa M Buck$2,416,496
- Ruchira Menka Jha$3,983,339
- Leo E Otterbein$8,123,287
- Anthony J Molina$9,321,229
Others in their field
Top investigators on “Critical Illness”
- Jonathan Michael Dean · University Of Utah$52,116,961
- Robert H Tukey · University Of California San Diego$50,968,168
- Mark R Farfel · Hugo W. Moser Res Inst Kennedy Krieger$37,361,278
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$35,137,697
- Steven M Greenberg · Massachusetts General Hospital$31,323,044
- Natalia S Rost · Massachusetts General Hospital$31,323,044
Research focus
Critical IllnessHourCessation Of LifeMortalityDialysis ProcedureRenal Replacement TherapyResponseObservational StudyEffective TherapyDependenceAcute Renal Failure With Renal Papillary NecrosisRandomized Clinical TrialsResourcesPreventEventPatient MonitoringMortality RiskClinical PracticeKidney DiseasesMissionClinical TrialsCardiacPhysiciansInjury
Grant awards (12)
AI driven acute renal replacement therapy - (AID-ART)$584,060
R01 · FY2024 · DK · contact PI
AI driven acute renal replacement therapy - (AID-ART)$616,773
R01 · FY2023 · DK · contact PI
REstrictive versus LIberal rate of Extracorporeal Volume removal Evaluation in Acute Kidney Injury (RELIEVE-AKI)$318,000
R01 · FY2023 · DK · contact PI
AI driven acute renal replacement therapy - (AID-ART)$628,057
R01 · FY2022 · DK · contact PI
REstrictive versus LIberal rate of Extracorporeal Volume removal Evaluation in Acute Kidney Injury (RELIEVE-AKI)$318,000
R01 · FY2022 · DK · contact PI
AI driven acute renal replacement therapy - (AID-ART)$639,669
R01 · FY2021 · DK · contact PI
REstrictive versus LIberal rate of Extracorporeal Volume removal Evaluation in Acute Kidney Injury (RELIEVE-AKI)$328,766
R01 · FY2021 · DK · contact PI
Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)$268,554
R01 · FY2020 · DK · contact PI
Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)$268,709
R01 · FY2019 · DK · contact PI
Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)$29,689
R01 · FY2018 · DK · contact PI
Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)$272,125
R01 · FY2017 · DK · contact PI
Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)$264,208
R01 · FY2016 · DK · contact PI